ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- EBITDA, 2025
- $8.7B
- YoY, 2025
- −5.5%
- 5-year CAGR
- +3.1%
- 10-year CAGR
- +6.1%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $8.7B | −5.5% |
| 2024 | $9.3B | −9.7% |
| 2023 | $10.2B | +2.9% |
| 2022 | $10.0B | +12.4% |
| 2021 | $8.9B | +17.9% |
| 2020 | $7.5B | +5.4% |
| 2019 | $7.1B | +28.5% |
| 2018 | $5.6B | +29.5% |
| 2017 | $4.3B | −12.6% |
| 2016 | $4.9B | +0.9% |
| 2015 | $4.9B | +7.4% |
| 2014 | $4.5B | +10.1% |
| 2013 | $4.1B | +10.3% |
| 2012 | $3.7B | −3.9% |
| 2011 | $3.9B | −7.2% |
| 2010 | $4.2B | −2.5% |
| 2009 | $4.3B | −3.7% |
| 2008 | $4.5B | — |